Purchase Order 75N92E19P00182

<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $10,517.76 on March 28, 2019, with completion due April 26, 2019. Place of performance is San Diego, California. The order is firm fixed price with no set-aside category. Specific procurement details regarding the items or services ordered are not provided in the source.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $9,715.00 on October 19, 2017, with an ultimate completion date of November 18, 2017. Work is performed in North Bethesda, Maryland. The order is firm fixed price with no set-aside. The source does not specify the technical scope of materials or services procured under this purchase order.</p>

<p>The National Human Genome Research Institute issued a $24,926.45 delivery order to Illumina, Inc. on September 19, 2019, under a firm fixed-price structure.</p> <p>Place of performance is Bethesda, MD. The order was due for completion on September 2, 2020. No set-aside was applied to this delivery order.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $13,250.00 on October 29, 2019, with an ultimate completion date of October 28, 2020. Work is performed in San Diego, California. The order is a firm fixed-price purchase for sequencing reagents, consumables, or related instrumentation—Illumina's core product line sold to NIH institutes and other federal research agencies. No set-aside applies.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $15,314.69 on August 23, 2017, with an ultimate completion date of September 22, 2017. Work is performed in North Bethesda, Maryland. The order covers sequencing reagents and consumables under firm fixed price terms. No set-aside applied.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $18,172.88 for scientific equipment, effective October 31, 2019 with ultimate completion on December 28, 2020. Work is performed in San Diego, California. The order is for a service agreement related to scientific equipment, priced on a firm fixed-price basis with no small business set-aside.</p>

<p>The National Human Genome Research Institute (National Institutes of Health) awarded a purchase order to Illumina, Inc. valued at $208,735.16 on June 5, 2026, for firm fixed-price procurement with no set-aside designation. Work is performed in San Diego, California. The order is scheduled for ultimate completion by September 22, 2027.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $17,735.76 on December 21, 2018, with completion by December 25, 2019. The order is a firm fixed price acquisition with no set-aside. Work is performed at Bethesda, Maryland. The purchase order procures DNA and RNA sequencing instruments, reagents, consumables, or bioinformatics software—Illumina's core product lines serving federal health and research agencies.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $15,314.69 on July 31, 2018, with final completion by August 29, 2018. The order is firm fixed price with no set-aside. Performance occurs in Bethesda, Maryland. The purchase order procures sequencing reagents, consumables, or related bioinformatics products from Illumina's core portfolio of DNA and RNA sequencing supplies and software.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $22,472.64 on December 18, 2018. Place of performance is Bethesda, Maryland. The order carries firm fixed price terms with an ultimate completion date of December 18, 2018. No set-aside was used. The specific goods or services procured are not identified in the source.</p>